AAPS supports credible science in pharmaceutical research literature
AAPS joins STEM organizations from across the breadth of the sciences in recognizing Peer Review Week, September 15-19, 2025. This week-long celebration highlights the value of peer review in ensuring credibility in research.
This year’s theme is ‘Rethinking Peer Review in the AI Era.’ The topic of AI and its impact on peer review was the focus of the opening session of the 2024 PharmSci 360, which featured a panel discussion with Ivan Oransky, Co-founder of Retraction Watch (NY, USA) and Colby Vorland, Assistant Research Scientist at the Indiana University School of Public Health-Bloomington (IN, USA).
“As forewarned during the opening session of the 2024 PharmSci 360, the inappropriate use of generative AI to perform peer review of submitted papers is a growing threat,” AAPS PharmSciTech Editor-in-Chief Robert O. (Bill) Williams III, explained. “What are AAPS editors doing in response? We are scrutinizing the submission and peer review processes by stepping up our due diligence and confirming that our peer reviewers maintain ethical standards as they fulfill their essential role in science.”
Through its four peer-reviewed journals (The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open), AAPS supports ethical, credible science with the help of hundreds of scientist volunteers who share their time and expertise by participating in peer review. Independent peer reviewers for these publications are critical to assuring the quality of scientific research used in the development of products and therapies that improve global health.
In recognition of Peer Review Week, AAPS will open the eLearning webinars, ‘Publish or Perish: Peer Review in the Pharmaceutical Sciences’ and ‘Understanding the ‘Dreaded’ Manuscript Review Process’ to non-members for a limited time. In addition, the recording of the 2024 PharmSci 360 research integrity panel will be open to view. These can all be accessed on the AAPS Science 360 portal.
Peer Review Week is September 15-19. Learn more about the event here.
More content from AAPS
- AAPS Elevates Eight Members to Fellow Status
- Healthcare, Finance and Smart Materials Experts Deliver Opening and Closing Plenaries at PharmSci 360
- AAPS 2025 Summer Scientific Forum round-up
About AAPS
The American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org
AAPS journals publish articles covering the breadth of pharmaceutical science, including complementary disciplines like chemistry, biology, and engineering. AAPS publishes four peer-reviewed journals: The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open. The latter is AAPS’ first fully open-access journal. It is freely available worldwide, and authors retain copyright. All four are available with AAPS membership or through institutional access. www.aaps.org/journals
In association with:
